There are several lines of evidence supporting the existence of a pivotal role of the cannabinoid system in mediating the reinforcing effects of nicotine. Characterization of the crosstalk between nicotine addiction and the cannabinoid system may have significant implications for our understanding of the neurobiological mechanisms underlying nicotine dependence. Objectives: The current series of experiments, we investigated the effects of activating CB1 receptors, modulating CB2 receptors as well as elevating levels of the endogenous cannabinoid ligand anandamide on nicotine taking and reinstatement of nicotine seeking behaviour. METHODS: In the first series of experiments, we investigated the effects of pretreatment with the CB receptor agonist WIN 55, 212-2 (0.1-1mg/kg), on nicotine self-administration and on the reinstatement of nicotine seeking behaviour. In the next series of experiments, we used a selective CB1 inverse agonist rimonabant (0.3mg/kg) and CB2 antagonist AM630 (5mg/kg) to delineate wether the effects obsereved with WIN 55, 212-2 are CB1 or CB2 meidated. Moreover, we investigated the effect of selective CB2 receptor activation (AM1241 1-10 mg/kg) and inhibition (AM630 1.25-5 mg/kg) on nicotine self-administration under fixed ratio (FR) and progressive (PR) schedules of reinforcement and on reinstatement of nicotine seeking induced by nicotine associated cues and nicotine priming. Finally, the effects of activation of CB receptors through administration of anandamide reuptake inhibitor VDM11 (1-10 mg/kg) on nicotine self-administration and on reinstatement of nicotine seeking were investigated. RESULTS: WIN 55,212-2 enhanced the break points for nicotine self-administration under a PR schedule of reinforcement, reinstated nicotine seeking behaviour and enhanced cue induced reinstatement of nicotine seeking. Neither activation nor blockade of CB2 receptors affected the responding of the animals for nicotine self-administration under FR or PR schedules of reinforcement or for reinstatement of nicotine seeking induced by nicotine associated cues and priming. Pretreatment with VDM11 dose dependently attenuated the reinstatement of nicotine seeking behaviour induced by nicotine associated cues and priming without affecting stable nicotine self administration. CONCLUSION: CB1 but not CB2 receptors appear to play a pivotal role in modulating the reinforcing effects of nicotine. Inhibition of anandamide reuptake could be a potentially useful tool in modulating relapse to smoking

There are several lines of evidence supporting the existence of a pivotal role of the cannabinoid system in mediating the reinforcing effects of nicotine. Characterization of the crosstalk between nicotine addiction and the cannabinoid system may have significant implications for our understanding of the neurobiological mechanisms underlying nicotine dependence. Objectives: The current series of experiments, we investigated the effects of activating CB1 receptors, modulating CB2 receptors as well as elevating levels of the endogenous cannabinoid ligand anandamide on nicotine taking and reinstatement of nicotine seeking behaviour. METHODS: In the first series of experiments, we investigated the effects of pretreatment with the CB receptor agonist WIN 55, 212-2 (0.1-1mg/kg), on nicotine self-administration and on the reinstatement of nicotine seeking behaviour. In the next series of experiments, we used a selective CB1 inverse agonist rimonabant (0.3mg/kg) and CB2 antagonist AM630 (5mg/kg) to delineate wether the effects obsereved with WIN 55, 212-2 are CB1 or CB2 meidated. Moreover, we investigated the effect of selective CB2 receptor activation (AM1241 1-10 mg/kg) and inhibition (AM630 1.25-5 mg/kg) on nicotine self-administration under fixed ratio (FR) and progressive (PR) schedules of reinforcement and on reinstatement of nicotine seeking induced by nicotine associated cues and nicotine priming. Finally, the effects of activation of CB receptors through administration of anandamide reuptake inhibitor VDM11 (1-10 mg/kg) on nicotine self-administration and on reinstatement of nicotine seeking were investigated. RESULTS: WIN 55,212-2 enhanced the break points for nicotine self-administration under a PR schedule of reinforcement, reinstated nicotine seeking behaviour and enhanced cue induced reinstatement of nicotine seeking. Neither activation nor blockade of CB2 receptors affected the responding of the animals for nicotine self-administration under FR or PR schedules of reinforcement or for reinstatement of nicotine seeking induced by nicotine associated cues and priming. Pretreatment with VDM11 dose dependently attenuated the reinstatement of nicotine seeking behaviour induced by nicotine associated cues and priming without affecting stable nicotine self administration. CONCLUSION: CB1 but not CB2 receptors appear to play a pivotal role in modulating the reinforcing effects of nicotine. Inhibition of anandamide reuptake could be a potentially useful tool in modulating relapse to smoking

As doenças neurodegenerativas são desordens progressivas que afetam determinadas populações neuronais do sistema nervoso central, levando a morte neuronal. Vários fatores contribuem para o desenvolvimento das doenças neurodegenerativas, dentre eles o aumento da formação de radicais livres e/ou estresse oxidativo. O sistema canabinóide vem sendo sugerido como um importante sistema neuroprotetor em diversos modelos de neurodegeneração. Os objetivos do presente estudo foram avaliar a participação do sistema canabinóide em um modelo de morte celular in vitro induzida pelo peróxido de hidrogênio. O modelo celular utilizado foi a linhagem Neuro 2A. Realizamos os tratamentos conjugados para verificar a possível função neuroprotetora do sistema canabinóide. Obtivemos resultados de neuroproteção da Metanandamida revertendo o quadro de morte celular induzido pelo peróxido de hidrogênio. Acreditamos que esta neuroproteção seja via CB1 que inibe os canais de cálcio dependentes de voltagem talvez contribuindo para a redução da progressão da excitotoxicidade. / Neurodegenerative diseases are progressive disorder affecting specific neuronal populations in the central nervous system, leading to neuronal death. Several factors contribute to the development of neurodegenerative diseases, including increased free radical formation and / or oxidative stress. The cannabinoid system has been suggested as an important system neuroprotective in several models of neurodegeneration. The objectives of this study were to evaluate the involvement of the cannabinoid system in a model of in vitro cell death induced by hydrogen peroxide. The model used was the cell line Neuro 2A. Performed the treatments combined to verify the possible neuroprotective effects of the cannabinoid system. We obtained results of neuroprotection Methanandamide reversing the framework of cell death induced by hydrogen peroxide. We believe that this is via neuroprotection CB1 that inhibits calcium channels of voltage-dependent perhaps contributing to the reduction of the progression of excitotoxicity.

As doenças neurodegenerativas são desordens progressivas que afetam determinadas populações neuronais do sistema nervoso central, levando a morte neuronal. Vários fatores contribuem para o desenvolvimento das doenças neurodegenerativas, dentre eles o aumento da formação de radicais livres e/ou estresse oxidativo. O sistema canabinóide vem sendo sugerido como um importante sistema neuroprotetor em diversos modelos de neurodegeneração. Os objetivos do presente estudo foram avaliar a participação do sistema canabinóide em um modelo de morte celular in vitro induzida pelo peróxido de hidrogênio. O modelo celular utilizado foi a linhagem Neuro 2A. Realizamos os tratamentos conjugados para verificar a possível função neuroprotetora do sistema canabinóide. Obtivemos resultados de neuroproteção da Metanandamida revertendo o quadro de morte celular induzido pelo peróxido de hidrogênio. Acreditamos que esta neuroproteção seja via CB1 que inibe os canais de cálcio dependentes de voltagem talvez contribuindo para a redução da progressão da excitotoxicidade. / Neurodegenerative diseases are progressive disorder affecting specific neuronal populations in the central nervous system, leading to neuronal death. Several factors contribute to the development of neurodegenerative diseases, including increased free radical formation and / or oxidative stress. The cannabinoid system has been suggested as an important system neuroprotective in several models of neurodegeneration. The objectives of this study were to evaluate the involvement of the cannabinoid system in a model of in vitro cell death induced by hydrogen peroxide. The model used was the cell line Neuro 2A. Performed the treatments combined to verify the possible neuroprotective effects of the cannabinoid system. We obtained results of neuroprotection Methanandamide reversing the framework of cell death induced by hydrogen peroxide. We believe that this is via neuroprotection CB1 that inhibits calcium channels of voltage-dependent perhaps contributing to the reduction of the progression of excitotoxicity.

Con la finalidad de explorar con profundidad las bases neurobiológicas de la adicción a cannabinoides hemos llevado a cabo diferentes estudios farmacológicos y moleculares. El sustrato neuroanatómico de la dependencia física de cannabinoides ha sido investigado en ratones que recibieron un tratamiento crónico con el agonista WIN55,212-2. En este estudio, se observó que el cerebelo y en menor grado el hipocampo y la amígdala, participan en la manifestación comportamental del síndrome de abstinencia de cannabinoides. Estas tres áreas se caracterizan por presentar una alta densidad de receptores cannabinoides CB1. Además, hemos evaluado la participación de diversos sistemas de neurotransmisión como son los sistemas opioide y purinérgico endógenos, en las respuestas comportamentales inducidas tras la administración de cannabinoides. Especialmente, nos hemos interesado por aquellas respuestas que están estrechamente relacionadas con las propiedades adictivas de dichos compuestos, como son los efectos reforzantes y aversivos y el desarrollo de dependencia física. Para ello hemos utilizado ratones modificados genéticamente. El sistema opioide endógeno ha sido relacionado con la manifestación de las propiedades adictivas de los cannabinoides. En este trabajo, mediante la utilización de ratones dobles mutantes MOR/DOR, hemos demostrado que se requiere una acción cooperativa entre ambos tipos de receptores opioides para que el síndrome de abstinencia cannabinoide se exprese enteramente. Por otro lado, los ratones con una supresión del gen que codifica para el receptor de adenosina A2A no mostraron ni preferencia de plaza ni aversión de plaza condicionadas a la administración de THC. Además, estos ratones presentaron un síndrome de abstinencia de THC de menor severidad, lo que sugiere una participación específica de los receptores A2A en efectos de los cannabinoides relacionados con sus propiedades adictivas. Finalmente, teniendo en cuenta que el sistema cannabinoide parece estar implicado en la modulación de las propiedades adictivas de otras drogas de abuso como opiáceos, etanol, cocaína y MDMA, hemos investigado la posible implicación del sistema cannabinoide en las propiedades adictivas de la nicotina. Para ello, hemos evaluado las respuestas comportamentales inducidas tras la administración aguda y crónica de nicotina en ratones deficientes del receptor cannabinoide CB1. En este sentido, nuestro principal hallazgo ha sido que las propiedades gratificantes de la nicotina no se manifiestan en los ratones mutantes sin el receptor cannabinoide CB1. Este hecho resulta de especial interés para la búsqueda de nuevas alternativas terapéuticas que faciliten el abandono del hábito tabáquico. / Cannabinoid addiction includes complex neurobiological and behavioural processes. Recently, several animal models allowing the exploration of the neurobiological basis of cannabinoid addiction have been developed. Acute cannabinoid reinforcing effects play a major role in the initiation of cannabinoid addiction, whereas the negative consequences of drug abstinence have a crucial motivational significance for relapse and maintenance of the addictive process. To further explore the neurobiological basis of cannabinoid addiction, we have conducted several pharmacological and molecular studies. The neuroanatomical substrate of cannabinoid physical dependence has been investigated in mice chronically receiving the cannabinoid agonist WIN 55,212-2. Interestingly, the cerebellum and in a lesser extent the hippocampus and the amygdala are shown to participate in the behavioural expression of cannabinoid withdrawal. All these brain areas have a high density of CB1 cannabinoid receptors. Moreover, we have evaluated the involvement of various neurotransmitter systems, such as the purinergic and opioid systems, in the behavioural responses of cannabinoids related to their addictive properties, including rewarding effects and the development of physical dependence. For this purpose, we have used genetically modified mice. Mice lacking A2A adenosine receptors reveal lower motivational responses to cannabinoids and a decreased cannabinoid withdrawal syndrome, suggesting a specific involvement of these receptors in the addictive-related properties of cannabinoids. On the other hand, the opioid system has also been implicated in the addictive properties of cannabinoids. Here, by using double mutants for mu- and delta-opioid receptors, we show that a cooperative action of both receptors is required for the entire expression of cannabinoid dependence. Finally, taking into account that the cannabinoid system has been reported to participate in the addictive properties of other drugs of abuse, such as ethanol, cocaine and MDMA, we have investigated the possible role of the cannabinoid system in the addictive properties of nicotine. We have evaluated nicotine behavioural responses in mice lacking CB1 cannabinoid receptors. In this regard, our main findings are that some acute effects and motivational responses of nicotine can be modulated by the endogenous cannabinoid system which could be of interest in order to find new therapies to facilitate tobacco smoking cessation.

L'étude de l'impact des facteurs environnementaux sur les effets à long-terme des psychostimulants a montré que des facteurs négatifs, comme le stress, augmentent le risque de développer une addiction, alors que des facteurs positifs, comme l'exposition à des conditions stimulantes, le réduisent. Une partie de cette thèse a consisté à rechercher les mécanismes neurobiologiques et cellulaires qui sous-tendent cette influence environnementale. Ainsi, l'exposition d'animaux à un environnement enrichi (EE), qui procure des conditions stimulantes, diminue leur niveau d'anxiété, un effet qui serait en partie lié à la régulation de gènes appartenant au système cannabinoïde endogène (SCE) dans des régions impliquées dans la réactivité au stress (article 1). Par ailleurs, nos travaux ont mis en évidence des limites de l'exposition à l'EE : quand celle-ci est interrompue, ses effets bénéfiques sont perdus et la vulnérabilité à la cocaïne est même augmentée. Ceci s'expliquerait par l'apparition d'un état émotionnel négatif, associé à une activation du facteur CREB dans l'amygdale étendue, une région carrefour entre la récompense et le stress (article 2). Nous nous sommes aussi intéressés à la toxicité de la méthamphétamine et à sa modulation par le SCE, pour lequel des propriétés neuroprotectives avaient déjà été suggérées. Ainsi, une stimulation pharmacologique du SCE permet de prévenir la neurotoxicité dopaminergique induite par la méthamphétamine (article 3). Nos résultats soulignent la complexité d'utilisation des manipulations environnementales et mettent en lumière les capacités protectives du SCE contre la dépendance et la neurotoxicité engendrées par les psychostimulants. / Studies of the impact of environmental factors on the long-term effects of psychostimulants have shown that negative factors, such as stress, increase the risk of developing drug addiction, while positive factors, such as exposure to stimulating conditions, reduce it. The first aim of this thesis work was to look for the neurobiological and cellular mechanisms that underlie this environmental influence. We found that exposure of animals to stimulating enriched environments (EE) reduces anxiety levels, an effect that may be partly related to the regulation of genes belonging to the endogenous cannabinoid system (ECS) in regions involved in stress reactivity (Article 1). In addition, our work has highlighted some limitations of the exposure to EE since discontinuation of enrichment results not only in the loss of its beneficial effects but also in increased vulnerability to cocaine. This effect is associated with emotional distress associated and changes in the activity of the transcription factor CREB in the extended amygdala, an interface region between reward and stress processes (Article 2). We also investigated whether ECS, for which neuroprotective properties have already been suggested, could reduce the brain toxicity induced by methamphetamine. We found that pharmacological stimulation of ECS provides protection against the methamphetamine-induced dopaminergic neurotoxicity (Article 3). Our results highlight the complex consequences of environmental conditions on brain and behavior and highlight the protective role of ECS against both addiction and neurotoxicity induced by psychostimulants.

O sistema canabinóide parece participar de vários processos neurobiológicos, incluindo neuroproteção e plasticidade. Os objetivos deste estudo foram avaliar os efeitos de ablações retinianas sobre a expressão do receptor canabinóide CB1 e de proteínas estruturais no tecto óptico de pintos pelos métodos de imuno-histoquímica, immunoblotting e PCR em tempo real. Além disso, avaliamos os efeitos do tratamento com agonistas e antagonistas canabinóides em culturas de células do tecto óptico expostas ao NMDA por citometria de fluxo e quanto à morfologia. A ablação retiniana parece gerar um aumento da expressão da proteína CB1 no tecto óptico desaferentado, mas não dos níveis de RNAm. O tratamento das culturas com o agonista canabinóide diminuiu o número de células inviáveis e de DNA fragmentado gerados pelo NMDA. O aumento da expressão de CB1 após a ablação indica uma localização pós-sináptica desses receptores e sugere um papel do sistema canabinóide em processos de plasticidade. Os resultados da cultura de células sugerem um papel neuroprotetor do sistema canabinóide. / The cannabinoid system (CS) seems to have a role in several neurobiological processes, including neuroprotection and neuronal plasticity. The aims of this study were to verify the effects of unilateral retinal ablation on the expression of cannabinoid receptor CB1 and other structural proteins in the optic tectum of chick brain by immunohistochemistry, immunoblotting and real time PCR. Moreover, we evaluated the effects of cannabinoids agonists and antagonists treatment in optic tectum cell cultures exposed to the NMDA by flow cytometry and in the morphology. The retinal ablation seems to generate an increase in the expression of protein CB1 in the deafferented optic tectum, but not in the levels of mRNA. The treatment of the cultures with the cannabinoid agonist decreased the number of unviable cells and fragmented DNAs generated by NMDA. This increase of CB1 expression indicates a post-synaptic localization of these receptors and suggests a role of the CS in plasticity processes. The results of cell culture suggest neuroprotector role of the CS.

O sistema canabinóide parece participar de vários processos neurobiológicos, incluindo neuroproteção e plasticidade. Os objetivos deste estudo foram avaliar os efeitos de ablações retinianas sobre a expressão do receptor canabinóide CB1 e de proteínas estruturais no tecto óptico de pintos pelos métodos de imuno-histoquímica, immunoblotting e PCR em tempo real. Além disso, avaliamos os efeitos do tratamento com agonistas e antagonistas canabinóides em culturas de células do tecto óptico expostas ao NMDA por citometria de fluxo e quanto à morfologia. A ablação retiniana parece gerar um aumento da expressão da proteína CB1 no tecto óptico desaferentado, mas não dos níveis de RNAm. O tratamento das culturas com o agonista canabinóide diminuiu o número de células inviáveis e de DNA fragmentado gerados pelo NMDA. O aumento da expressão de CB1 após a ablação indica uma localização pós-sináptica desses receptores e sugere um papel do sistema canabinóide em processos de plasticidade. Os resultados da cultura de células sugerem um papel neuroprotetor do sistema canabinóide. / The cannabinoid system (CS) seems to have a role in several neurobiological processes, including neuroprotection and neuronal plasticity. The aims of this study were to verify the effects of unilateral retinal ablation on the expression of cannabinoid receptor CB1 and other structural proteins in the optic tectum of chick brain by immunohistochemistry, immunoblotting and real time PCR. Moreover, we evaluated the effects of cannabinoids agonists and antagonists treatment in optic tectum cell cultures exposed to the NMDA by flow cytometry and in the morphology. The retinal ablation seems to generate an increase in the expression of protein CB1 in the deafferented optic tectum, but not in the levels of mRNA. The treatment of the cultures with the cannabinoid agonist decreased the number of unviable cells and fragmented DNAs generated by NMDA. This increase of CB1 expression indicates a post-synaptic localization of these receptors and suggests a role of the CS in plasticity processes. The results of cell culture suggest neuroprotector role of the CS.

La adicción es un trastorno crónico de la conducta caracterizado por la búsqueda y el consumo compulsivos de la droga, la pérdida de control para limitar dicho consumo, a aparición de un estado emocional negativo cuando el acceso a la droga está impedido y la recaída en el proceso incluso tras largos períodos de abstinencia. El sistema dopaminérgico mesolímbico cortical ha sido propuesto como la principal base neurobiológica de la adicción, sin embargo existen otros sistemas de neurotransmision que participan en la consolidación del proceso adictivo.El sistema endocannabinoide, a traves del receptor CB1, participa en las propiedades adictivas de diferentes drogas de abuso como el delta9-tetrahidrocannabinol, la nicotina y la morfina. Sin embargo, hasta el momento de iniciar este trabajo, pocos estudios han demostrado una clara implicación del sistema endocannabinoide en las propiedades reforzantes de los psicoestimulantes. Mediante el uso de ratones CB1 knockout, hemos demostrado que el receptor CB1 participa en la eficacia reforzante de la cocaína. Además, la presencia de dicho receptor es necesaria para los procesos de consolidación de una conducta operante mantenida por la autoadministración de cocaína. Este estudio demuestra la importancia de dicho receptor CB1 en las propiedades adictivas de la cocaína, confirmando que el sistema endocannabinoide es un sustrato común para la adicción de drogas de abuso. Por otra parte, el sistema purinérgico modula numerosos sistemas de neurotransmisión en el SNC. La estrecha relación a nivel celular y funcional entre los receptores de adenosina y los receptores dopaminérgicos proporciona evidencias de que el sistema purinérgico podría modular los sistemas de recompensa. Utilizando diferentes modelos animales, hemos demostrado que los receptores de adenosina A2A son necesarios para que las propiedades adictivas de las drogas de abuso como los cannabinoides, los opioides, la nicotina y los psicoestimulantes se produzcan de un modo completo.Nuestros estudios nos permiten afirmar que ambos sistemas, el cannabinoide y el purinérgico podría suponer la existencia de nuevos sistemas de modulación común de los procesos adictivos. Asi, sería de gran interés desarrollar nuevas estrategias de bloqueo de los receptores A2A y CB1 para atenuar e incluso prevenir el desarrollo de la adicción. / Drug addiction is a chronically relapsing disorder that is defined by a compulsion to take the drug intake, a loss of control in limiting intake and a withdrawal-negative affect state when the access to the drug is interrupted. Mesolimbic dopaminergic system has been proposed as a fundamental neurobiological substrate for drug addiction. However, there is evidence for other neurotransmitter systems involved in the consolidation of the addictive process. The endocannabinoid system, through the activation of CB1 receptor, participates in the addictive properties of different drugs of abuse such as delta9-tetrahydrocannabinol, morphine and nicotine. Nevertheless, few studies have revealed an important implication of CB1 receptor in the reinforcing properties of psychostimulants. By using CB1 knockout mice, we have demonstrated that CB1 receptor participates in the reinforcing efficacy of cocaine. Moreover, this receptor is necessary for the consolidation processes involved in cocaine maintained intravenous self-administration. Therefore, this study reveals an essential role of CB1 receptor in cocaine addictive properties, confirming that the endocannabinoid system is a common substrate of addiction to drugs of abuse.On the other hand, the purinergic system modulates different neurotransmitter systems in the CNS. Adenosine receptors are closely related to dopaminergic receptors at both cellular and functional levels, suggesting that purinergic system could modulate the reward systems. By using different animal models, we have demonstrated that A2A adenosine receptors are necessary for the development of the addictive properties of drugs of abuse such as opioids, cannabinoids, nicotine and cocaine. Our studies suggest that both cannabinoid and purinergic systems could represent new and common modulatory systems of addictive processes. Thus, it would be of interest to develop new therapeutic targets blocking CB1 and A2A receptors to attenuate the development of addiction.

Los trastornos emocionales de tipo depresivo y la ansiedad son las formas más prevalentes de enfermedad mental y suponen un serio problema de salud en la sociedad occidental. Recientemente, se ha postulado que el sistema endocannabinoide pueda ser un importante sustrato en el desarrollo de estos trastornos dada su participación en el control de las emociones. Nuestros resultados demuestran que los animales carentes del receptor cannabinoide CB1 manifiestan un fenotipo de tipo depresivo asociado a una deficiencia del factor neurotrófico BDNF en el hipocampo, que podría estar causada por los elevados niveles de glucocorticoides liberados en respuesta al estrés en estos mutantes. Por otra parte, el sistema endocannabinoide participa en los efectos inducidos por la nicotina sobre la ansiedad y en la expresión del síndrome de abstinencia de esta droga. Así, la actividad del receptor CB1 alivia los efectos ansiogénicos de dosis elevadas de nicotina y facilita los efectos ansiolíticos de dosis bajas. Además, la administración del agonista cannabinoide 9-THC atenúa las manifestaciones somáticas y emocionales negativas de la abstinencia de nicotina. En general, considerando los resultados presentados en esta Tesis Doctoral, podemos afirmar que el receptor CB1 participa de forma determinante en la recuperación del balance homeostático del organismo tras la exposición a un estímulo emocional negativo, bien sea una situación estresante aguda o sostenida, o bien una droga que incrementa los niveles de ansiedad o cuya retirada produce abstinencia. / Mood disorders such as depression and anxiety are the most common mental diseases and they suppose a serious health problem in our society. Recently, endocannabinoid system has been postulated to be an important substrate in the development of such disorders taking into account the role exerted by this neuromodulatory system in mood and emotions. Our results demonstrate that CB1 knockout mice exhibit a depressive-like phenotype associated to a deficiency in the neurotrophic factor BDNF in the hippocampus, which could be a consequence of the increased glucocorticoid release in response to stress exposure. On the other hand, the endocannabinoid system participates in nicotine induced effects on anxiety and in the expression of nicotine withdrawal. Thus, CB1 receptor activity attenuates anxiogenic-like effects and facilitates anxiolytic-like responses induced by high or low doses of nicotine, respectively. Moreover, 9-THC administration ameliorates somatic and negative motivational signs of nicotine withdrawal. In summary, the results presented in this Doctoral Thesis indicate that CB1 receptor participates in the recovery of the homeostatic balance after the exposure to negative emotional stimuli, either acute or sustained stress or a drug which induced anxiety-like effects or withdrawal signs after the end of the exposure.